Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
N-(4-tert-Butylbenzoyl)-2-hydroxynaphthaldehyde hydrazone (BBNH) is a potent inhibitor of the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV)-1 reverse transcriptase (RT). Molecular modeling predicted that BBNH binds to the HIV-1 RT RNase H active site via two major interactions, coordination to the metal ion cofactor (Mg(2+) or Mn(2+)) in the enzyme active site and aromatic ring-stacking interaction between the naphthyl ring of BBNH and amino acid Tyr-501. The latter residue equivalent is conserved in virtually all RNases H, suggesting the need for an aromatic or pi-stacking interaction in this region. To assess the importance of Tyr-501 in the binding of BBNH for the inhibition of RT RNase H activity, we used site-specific mutagenesis to generate RT with a variety of substitutions at this position. Most substitutions resulted virtually in a complete loss of RNase H activity. However, three mutants, Y501F, Y501W, and Y501R, possessed RNase H activities comparable with wild-type enzyme. Whereas BBNH inhibited Y501F RT RNase H activity with potency equivalent to wild-type RT, the Y501W mutant showed a 6-fold resistance to inhibition by BBNH, and the Y501R mutant was completely resistant to inhibition by BBNH. The replication "fitness" of HIV molecular clones with the Y501W or Y510R mutation was significantly compromised compared with wild-type virus. Importantly, BBNH was an effective inhibitor of the DNA polymerase activity of all Y501X mutants tested. Our results highlight the importance of Tyr-501 in RT RNase H activity and in N-acylhydrazone inhibitor binding and suggest that drugs that target critical residues in HIV-1 proteins may be a useful approach in new antiviral development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)
Sluis-Cremer, N., Arion, D., & Parniak*, M. A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000626 · Cited by 117
Self-citation
Research works printed but not linked: 21
- Parniak, 2000, Adv. Pharmacol., 49, 67, 10.1016/S1054-3589(00)49024-1 · DOI
- Loya, 1990, Antimicrob. Agents Chemother., 34, 2009, 10.1128/AAC.34.10.2009 · DOI
- Tan, 1991, Biochemistry, 30, 4831, 10.1021/bi00234a001 · doi:10.1021/bi00234a001
- Zhan, 1994, Biochemistry, 33, 1366, 10.1021/bi00172a012 · DOI
- Mohan, 1994, J. Med. Chem., 37, 2513, 10.1021/jm00042a004 · DOI
- Loya, 1997, J. Virol., 71, 5668, 10.1128/JVI.71.7.5668-5672.1997 · DOI
- Buckheit, 1999, Antiviral Chem. Chemother., 1, 23, 10.1177/095632029901000103 · DOI
- Hnatyszyn, 1999, Phytother. Res., 13, 206, 10.1002/(SICI)1099-1573(199905)13:3<206::AID-PTR409>3.0.CO;2-D · doi:10.1002/(sici)1099-1573(199905)13:3<206::aid-ptr409>3.0.co;2-d
- Min, 2000, Chem. Pharm. Bull. (Tokyo), 48, 194, 10.1248/cpb.48.194 · doi:10.1248/cpb.48.194
- Borkow, 1997, Biochemistry, 36, 3179, 10.1021/bi9624696 · DOI · Paper page
- Gabbara, 1999, Biochemistry, 38, 13070, 10.1021/bi991085n · doi:10.1021/bi991085n
- Baker, 1992, Hepatology, 15, 492, 10.1002/hep.1840150323 · DOI · Paper page
- Edward, 1988, J. Chem. Eng. Data, 33, 538, 10.1021/je00054a044 · DOI · Paper page
- Lanthier, 1997, Bioorg. Med. Chem. Lett., 7, 1557, 10.1016/S0960-894X(97)00267-9 · DOI
- Fletcher, 1996, Protein Expression Purif., 7, 27, 10.1006/prep.1996.0004 · DOI
- Arts, 1994, J. Biol. Chem., 269, 14672, 10.1016/S0021-9258(17)36678-4 · DOI · Paper page
- Fisher, 1991, Nature, 316, 262, 10.1038/316262a0 · DOI · Paper page
- Gopalakrishnan, 1994, J. Biol. Chem., 269, 4110, 10.1016/S0021-9258(17)41750-9 · DOI
- Mizuguchi, 1998, Protein Sci., 7, 2469, 10.1002/pro.5560071126 · DOI · Paper page
- Ding, 1998, J. Mol. Biol., 284, 1095, 10.1006/jmbi.1998.2208 · DOI · Paper page
- Huang, 1998, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page
Cited by
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Self-citationRNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
“Modeling studies have suggested that Y501 is important for BBNH binding [100].”
BackgroundResultRibonuclease H: properties, substrate specificity and roles in retroviral reverse transcription
Champoux, J. J., & Schultz, S. J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06909.x · Cited by 77
Camarasa, M.-J., Velázquez, S., San-Félix, A., Pérez-Pérez, M.-J., & Gago, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.021 · Cited by 66
Metadata
- Authors
- Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1370-1374
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2078861644
- Cited by
- 50
- References
- 2
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase. https://app.cochat.ai/papers/10.1074/jbc.m110254200
- The paper
- Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A. (2002). Mutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m110254200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.